is semaglutide fda approved for obesity GLP-1 Safe Weight Loss? What's New in Obesity Treatment?

Understanding why semaglutide causes digestive side effects requires examination of its pharmacological mechanism and the physiological role of GLP-1 in gastrointestinal function

These symptoms are primarily due to the mode of action of GLP-1 RAs on the gut, as a GLP-1 may directly or indirectly regulate electrolyte and fluid homeostasis by influencing feeding and drinking behavior as well as electrolyte transport in the kidneys and gastrointestinal tract [25]

PlexusDx works with patients to adjust compounded semaglutide therapy based on your tolerance profileyour dose may need to go up, but your price won't

doi:10.2106/jbjs.20.01535 Witkowski M, Friebel J, Tabaraie T, et al